Cargando…

Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients

SIMPLE SUMMARY: Histological transformation remains the leading cause of death in patients diagnosed with follicular lymphoma (FL). To date, no clinical nor biological biomarkers have been identified to unequivocally predict patients in high risk of transformation. In this study, we investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enemark, Marie Beck, Hybel, Trine Engelbrecht, Madsen, Charlotte, Lauridsen, Kristina Lystlund, Honoré, Bent, Plesner, Trine Lindhardt, Hamilton-Dutoit, Stephen, d’Amore, Francesco, Ludvigsen, Maja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909114/ https://www.ncbi.nlm.nih.gov/pubmed/35267625 http://dx.doi.org/10.3390/cancers14051316

Ejemplares similares

High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma
por: Madsen, Charlotte, et al.
Publicado: (2019)

IDO1 Protein Is Expressed in Diagnostic Biopsies from Both Follicular and Transformed Follicular Patients
por: Enemark, Marie Beck Hairing, et al.
Publicado: (2023)

Glycolytic biomarkers predict transformation in patients with follicular lymphoma
por: Monrad, Ida, et al.
Publicado: (2020)

PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation
por: Beck Enemark, Marie, et al.
Publicado: (2021)

Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia
por: Holst, Johanne Marie, et al.
Publicado: (2021)

Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma
por: Ludvigsen, M, et al.
Publicado: (2015)

Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation
por: Holst, Johanne Marie, et al.
Publicado: (2021)

Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling
por: Honoré, Bent, et al.
Publicado: (2022)

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
por: Ludvigsen, Maja, et al.
Publicado: (2023)

Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells
por: Veiseh, Mandana, et al.
Publicado: (2015)

Editorial: Interaction Between Hyaluronic Acid and Its Receptors (CD44, RHAMM) Regulates the Activity of Inflammation and Cancer
por: Naor, David
Publicado: (2016)

Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma
por: Shigeeda, Wataru, et al.
Publicado: (2017)

The Pro-fibrotic Response of Mesenchymal Leader Cells to Lens Wounding Involves Hyaluronic Acid, Its Receptor RHAMM, and Vimentin
por: Menko, A. Sue, et al.
Publicado: (2022)

“RHAMM knockout” mice express a truncated RHAMM protein that promotes pancreatic cancer progression with dysfunctional p53
por: Chen, Xiang, et al.
Publicado: (2022)

Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients
por: Petersen, Marianne Agerlund, et al.
Publicado: (2022)

Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma
por: Wang, Dunrui, et al.
Publicado: (2016)

Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors
por: Yang, Chenchen, et al.
Publicado: (2017)

Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity
por: Ludvigsen, Maja, et al.
Publicado: (2009)

Proteomic Analysis of Tissue from α1,3-galactosyltransferase Knockout Mice Reveals That a Wide Variety of Proteins and Protein Fragments Change Expression Level
por: Thorlacius-Ussing, Louise, et al.
Publicado: (2013)

Hyaluronan and RHAMM in Wound Repair and the “Cancerization” of Stromal Tissues
por: Tolg, Cornelia, et al.
Publicado: (2014)

RHAMM deficiency disrupts folliculogenesis resulting in female hypofertility
por: Li, Huaibiao, et al.
Publicado: (2015)

Increased RHAMM expression relates to ovarian cancer progression
por: Buttermore, Stephanie T., et al.
Publicado: (2017)

RHAMM Is a Multifunctional Protein That Regulates Cancer Progression
por: Messam, Britney J., et al.
Publicado: (2021)

The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilities
por: Hinneh, Josephine A., et al.
Publicado: (2022)

Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort
por: Holst, Johanne M., et al.
Publicado: (2019)

Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression
por: Choi, Soyoung, et al.
Publicado: (2019)

RHAMM Expression in the Rat Endometrium during the Estrous Cycle and following Implantation
por: Ozbilgin, Kemal, et al.
Publicado: (2012)

RHAMM marks proliferative subpopulation of human colorectal cancer stem cells
por: Nakano, Michitaka, et al.
Publicado: (2023)

Serum Proteomic Changes after Randomized Prolonged Erythropoietin Treatment and/or Endurance Training: Detection of Novel Biomarkers
por: Christensen, Britt, et al.
Publicado: (2015)

Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers
por: Ludvigsen, Maja, et al.
Publicado: (2021)

MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma
por: Leivonen, Suvi-Katri, et al.
Publicado: (2017)

Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients
por: Egeland, Nina Gran, et al.
Publicado: (2020)

Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma – A study from the Danish Lymphoma Registry
por: Andersen, Maja Dam, et al.
Publicado: (2022)

RHAMM splice variants confer radiosensitivity in human breast cancer cell lines
por: Schütze, Alexandra, et al.
Publicado: (2016)

RHAMM induces progression of rheumatoid arthritis by enhancing the functions of fibroblast-like synoviocytes
por: Wu, Jing, et al.
Publicado: (2018)

The Application of Principal Component Analysis on Clinical and Biochemical Parameters Exemplified in Children With Congenital Adrenal Hyperplasia
por: Ljubicic, Marie Lindhardt, et al.
Publicado: (2021)

Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin
por: Aune Westergaard Hansen, Gry, et al.
Publicado: (2015)

Correction: Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin
por: Aune Westergaard Hansen, Gry, et al.
Publicado: (2015)

TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan
Publicado: (1993)

The hyaluronan-mediated motility receptor RHAMM promotes growth, invasiveness and dissemination of colorectal cancer
por: Mele, Valentina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3th9jqpk27p23euu9v8kada5k1